1. Biomimetic Nanobomb for Synergistic Therapy with Inhibition of Cancer Stem Cells. Issue 12 (1st January 2023) Authors: Liu, Shuang; Zhang, Tianshu; Li, Shanshan; Wu, Qingyuan; Wang, Kexin; Xu, Xican; Lu, MingZhu; Shao, Rongguang; Zhao, Wuli; Liu, Huiyu Journal: Small Issue: Volume 19:Issue 12(2023) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cytotoxic metabolites from the endophytic fungus Chaetomium globosum 7951. Issue 28 (21st May 2019) Authors: Wang, Fang; Zhao, Wuli; Zhang, Conghui; Chang, Shanshan; Shao, Rongguang; Xing, Jianguo; Chen, Minghua; Zhang, Yixuan; Si, Shuyi Journal: RSC advances Issue: Volume 9:Issue 28(2019) Page Start: 16035 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Design, synthesis and biological evaluation of 2-((4-sulfamoylphenyl)amino)-pyrrolo[2, 3-d]pyrimidine derivatives as CDK inhibitors. (31st December 2023) Authors: Yang, Bo; Quan, Yanni; Zhao, Wuli; Ji, Yingjie; Yang, Xiaotang; Li, Jianrui; Li, Yi; Liu, Xiujun; Wang, Ying; Li, Yanping Journal: Journal of enzyme inhibition and medicinal chemistry Issue: Volume 38:Number 1(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Evaluation of antitumor efficacy of folate-poly(2-ethyl-2-oxazoline)-distearoyl phosphatidyl ethanolamine based liposome. (2nd January 2021) Authors: Wang, Xiaowei; Li, Yunfei; Wang, Dan; Wang, Xuelei; Yuan, Wei; Zhao, Wuli; Xia, Guimin Journal: Pharmaceutical development and technology Issue: Volume 26:Number 1(2021) Page Start: 110 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Lidamycin inhibits tumor initiating cells of hepatocellular carcinoma Huh7 through GSK3β/β‐catenin pathway. Issue 1 (16th July 2013) Authors: Chen, Yi; Yu, Dongke; Zhang, Caixia; Shang, Boyang; He, Hongwei; Chen, Jinjing; Zhang, Hao; Zhao, Wuli; Wang, Zhen; Xu, Xiaoyu; Zhen, Yongsu; Shao, Rong‐guang Journal: Molecular carcinogenesis Issue: Volume 54:Issue 1(2015:Jan.) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Lidamycin inhibits tumor initiating cells of hepatocellular carcinoma Huh7 through GSK3β/β‐catenin pathway. Issue 1 (16th July 2013) Authors: Chen, Yi; Yu, Dongke; Zhang, Caixia; Shang, Boyang; He, Hongwei; Chen, Jinjing; Zhang, Hao; Zhao, Wuli; Wang, Zhen; Xu, Xiaoyu; Zhen, Yongsu; Shao, Rong‐guang Journal: Molecular carcinogenesis Issue: Volume 54:Issue 1(2015:Jan.) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Myofibrillogenesis regulator 1 (MR-1): a potential therapeutic target for cancer and PNKD. (14th September 2018) Authors: Wang, Junxia; Zhao, Wuli; Liu, Hong; He, Hongwei; Shao, Rongguang Journal: Journal of drug targeting Issue: Volume 26:Number 8(2018) Page Start: 643 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. New dimeric chromanone derivatives from the mutant strains of Penicillium oxalicum and their bioactivities. Issue 35 (10th August 2022) Authors: Gu, Guowei; Zhang, Tao; Zhao, Jianyuan; Zhao, Wuli; Tang, Yan; Wang, Lu; Cen, Shan; Yu, Liyan; Zhang, Dewu Journal: RSC advances Issue: Volume 12:Issue 35(2022) Page Start: 22377 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Phosphorylation of myofibrillogenesis regulator‐1 activates the MAPK signaling pathway and induces proliferation and migration in human breast cancer MCF7 cells. Issue 17 (24th July 2014) Authors: Gong, Yuyan; He, Hongwei; Liu, Hong; Zhang, Caixia; Zhao, Wuli; Shao, Rong-guang Journal: FEBS letters Issue: Volume 588:Issue 17(2014) Page Start: 2903 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. The anti‐hepatic fibrosis effects of dihydrotanshinone I are mediated by disrupting the yes‐associated protein and transcriptional enhancer factor D2 complex and stimulating autophagy. (6th April 2017) Authors: Ge, Maoxu; Liu, Hong; Zhang, Yixuan; Li, Naren; Zhao, Shuangshuang; Zhao, Wuli; Zhen, Yongzhan; Yu, Jianzhong; He, Hongwei; Shao, Rong‐guang Journal: British journal of pharmacology Issue: Volume 174:Number 10(2017) Page Start: 1147 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗